News
-
-
PRESS RELEASE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Drägerwerk AG & Co. KGaA reports significant earnings growth in Q1 2026, with net sales up by 6.9%. Positive trends in both medical and safety divisions drive increase in EBIT and order intake -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Dräger with good order development, record net sales and significant increase in net profit in fiscal year 2025 – third dividend increase in a row
Drägerwerk AG & Co. KGaA reports record net sales and significant profit increase for fiscal year 2025, along with a third consecutive dividend hike -
-
PRESS RELEASE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2025: Record net sales and significant earnings growth – forecast for 2026
Drägerwerk AG & Co. KGaA reports record net sales and significant earnings growth in 2025, with a forecast for 2026. Medical and safety divisions contribute to the positive results -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
Drägerwerk AG & Co. KGaA completed the share buyback for the annual employee stock program as of November 12, 2025, with a total of 70,000 preferred shares repurchased from June 3 to July 18 -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Dräger with strong demand, noticeable net sales growth and very good earnings performance in the first nine months of 2025
Drägerwerk AG & Co. KGaA reports strong demand, noticeable net sales growth, and very good earnings performance in the first nine months of 2025, with order intake and EBIT up
